Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055814
Filing Date
2021-11-09
Accepted
2021-11-09 17:14:21
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stsa-10q_20210930.htm   iXBRL 10-Q 2515639
2 EX-31.1 stsa-ex311_8.htm EX-31.1 21717
3 EX-31.2 stsa-ex312_6.htm EX-31.2 21475
4 EX-32.1 stsa-ex321_7.htm EX-32.1 9911
5 EX-32.2 stsa-ex322_9.htm EX-32.2 9835
  Complete submission text file 0001564590-21-055814.txt   7058122

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA stsa-20210930.xsd EX-101.SCH 38801
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stsa-20210930_cal.xml EX-101.CAL 37382
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stsa-20210930_def.xml EX-101.DEF 101172
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stsa-20210930_lab.xml EX-101.LAB 308204
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stsa-20210930_pre.xml EX-101.PRE 214843
11 EXTRACTED XBRL INSTANCE DOCUMENT stsa-10q_20210930_htm.xml XML 1177044
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39041 | Film No.: 211393245
SIC: 2834 Pharmaceutical Preparations